Abstract
Category:
Ankle; Other
Introduction/Purpose:
The purpose of this study was to evaluate the impact on cost effectives with in-office needle arthroscopy (IONA) for the management of anterior ankle pathologies in comparison to anterior ankle arthroscopy performed in a traditional formal operating suite.
Methods:
Data regarding costs was obtained from the local institution in the following areas: . A Monte Carlo simulation combined with DuPont analysis running 10,000 simulations was conducted to calculate the revenue, expenses and profits between the 2 cohorts. Sensitivity analyses examined the influence of patient preference and revision rates on profit and throughput. Two-sample Student's t test was performed (p < .05).
Results:
There was a 91.4% reduction in costs in favor of anterior ankle IONA. Sensitivity analysis revealed 4.3% of patients need to select IONA over traditional arthroscopy in an operating suite with the revision rate remaining below 42% for the proposed state profit to be higher than the current state.
Conclusion:
IONA is a cost-effective alternative to traditional OR arthroscopy in patients undergoing anterior ankle arthroscopy. The next steps are to assess patients' perceptions of IONA as an alternative to traditional OR arthroscopy, and to carry out clinical trials to determine the efficacy, patient-reported outcome metrics, and complications of IONA.